Format

Send to

Choose Destination
Am J Clin Oncol. 1998 Jun;21(3):246-7.

Carcinoid tumor regression with high-dose octreotide acetate: a patient report.

Author information

1
The Cancer Center of Boston, Massachussetts 02120, USA.

Abstract

A patient who had carcinoid tumor of the ileum and liver and intraabdominal lymph-node metastases sustained a substantial (more than 50%) reduction of metastatic tumor burden when treated with accelerated-dosage octreotide.

PMID:
9626790
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center